Episode 24 - Dr. Samuel Ewing and the New World of Digital Hospitals

The Future of Pharma

Innehåll tillhandahållet av Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

1M ago 36:42

MP3•Episod hem

My guest in this episode is Dr. Samuel Ewing. He is the Global Head of Pharmaceutical Partnerships at Doccla.

Before joining Doccla, Dr. Ewing led the development of a connected auto-injector system for Roche’s Alzheimer’s disease program at Capgemini Engineering. He also led the development of Biofourmis’s wearable vital sign monitoring platform.

At Roche, he managed remote patient monitoring across various diseases, including Parkinson’s, Huntington’s, Alzheimer’s, Multiple Sclerosis, and others. As Chief Neuroscience Officer at NeuroPro, he developed a wearable brain monitoring device for epilepsy.

Dr. Ewing's extensive experience in digital health and medical research drives his commitment to advancing treatment for challenging diseases. He believes that the scarcity of data from patients in the real world hinders progress, something he is committed to overcoming.

In this fascinating chat, we talk about our current hospital systems, and capacity, and how patients can get the hospital care in the comfort of their home in a digital hospital.

Here’s my guest Dr. Samuel Ewing.

26 episoder

#Science #Fitness #Medicine #Samir Gondalia, ISPE Boston #ISPE Boston #Samir Gondalia #Boston #Gondalia #Healthcare #Innovation #Ispeboston #Pharma #Pharmaceutical #ISPE